Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSP #2016 - National Adaptive Trial for PTSD Related Insomnia
NCT03668041Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Feb 2021
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trazodone hydrochloride prolonged-release tablets, eszopiclone in Insomnia, sponsored by VA Office of Research & Development. Started Feb 2021; status: completed.
02
Drugs
trazodone hydrochloride prolonged-release tabletseszopiclone
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03668041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03668041.